Poulvac Procerta HVT-IBD-ND RSSAuthorisedThis medicine is authorised for use in the European UnionLive recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDVMedicineVeterinaryAuthorised
Page contentsOverviewProduct detailsAuthorisation detailsAssessment historyNews on Poulvac Procerta HVT-IBD-ND Application under evaluationCVMP opinionEuropean Commission decisionOverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information websiteProduct details Name of medicine Poulvac Procerta HVT-IBD-ND Active substance Live recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV International non-proprietary name (INN) or common name Live recombinant turkey herpes virus, strain HVT-IBD-ND, expressing the VP2 protein of IBDV and the F protein of NDV Anatomical therapeutic chemical veterinary (ATCvet) code QI01AD16 Pharmacotherapeutic groupImmunologicals for avesLive viral vaccinesavian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirusAuthorisation details EMA product number EMEA/V/C/006306 Assessment historyInitial marketing authorisation documentsCVMP summary of positive opinion for Poulvac Procerta HVT-IBD-NDAdoptedReference Number: EMA/CVMP/442900/2024 English (EN) (145.59 KB - PDF)First published: 06/12/2024ViewNews on Poulvac Procerta HVT-IBD-ND Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 December 202406/12/2024This page was last updated on 24/02/2025Share this page